BioBuzz’s Post

#StartupMahakumbh2024 Dr. Manish Diwan, leading the Strategic Partnership & Entrepreneurship Development division at Biotechnology Industry Research Assistance Council (BIRAC), shares insights on 'Funding DeepTech: Venture Capital's View on Research-Backed Startups' during his session at Startup Mahakumbh. #StartupMahakumbh2024 #StartupEcosystem #InvestInStartups #IAN #BioAngels #IndianStartups #InvestmentOpportunities #FutureEntrepreneurs #EmergingStartups

Michael Young talks learning curves in this week's #RisingFast: quick-fire insight from Europe's hottest startups, brought to you by CMC. At our recent event with WIRED, the Lindus Health Co-Founder told us how moving at a different pace in the biotech industry keeps things interesting. #RisingFast #CMCmarkets #wiredmagazine #startup #ForTheAchievers

Are you fundraising for your biotech/medtech company? Or are you preparing to begin fundraising? A strong regulatory strategy and successful regulatory engagements remain approaches companies can take to de-risk products for investors. Learn how you can leverage these to meet your milestones and goals in this complimentary, in-person discussion, co-sponsored by OnemataDC and Colorado Health & Tech Centers, including lunch and a tour of the incredible CHTC Greenwood Village Innovation Hub. Learn more and register 🔗 https://lnkd.in/gFtG8z52 Afshin Safavi #entrepreneurship #innovation #venturecapital #startups

Initiate Ventures, led by Jessica Owens and Iana Dimkova, launches with a $45M fund to drive innovation in healthcare. The firm combines early-stage investments with an in-house incubation model to support the next wave of life sciences startups. With a track record in both entrepreneurship and healthcare investment, Owens and Dimkova are positioned to make a lasting impact. The firm’s portfolio already includes five startups, including Persana and Macro Trials. More at: https://lnkd.in/eDYiipcT #HealthcareInnovation #VentureCapital #LifeSciences #Startups

Are you fundraising for your biotech/medtech company? Or are you preparing to begin fundraising? A strong regulatory strategy and successful regulatory engagements remain approaches companies can take to de-risk products for investors. Learn how you can leverage these to meet your milestones and goals in this complimentary, in-person discussion, co-sponsored by OnemataDC and Colorado Health & Tech Centers, including lunch and a tour of the incredible CHTC Greenwood Village Innovation Hub. Learn more and register 🔗 https://lnkd.in/g97qyUSs Afshin Safavi #entrepreneurship #innovation #venturecapital #startups

Scaling a bio-based start-up is tough but vital for sustainability. You need to connect, learn and grown but it can be hard to find the resources to attend big events. World Bio Markets 2024 is your opportunity to connect with customers, partners, and investors, and turn challenges into opportunities. Email paul@worldbiomarkets.com to find out more about our Early Stage Startup Delegate Pass. Join us this June to fuel your growth and innovation. #WBM24 #Bioeconomy #Sustainability #StartUps #WorldBioMarkets

just 10% of biotech startups successfully reach the stage of commercialization. This statistic sheds light on the challenges facing the biotech industry and the barriers that startups encounter in bringing their innovations to market. #BiotechIndustry #Startups #Research

Vento, a fund under Exor Ventures, has made a significant mark two years into its Italian chapter, investing in 60 startups out of over 2,400 applications. Now in its third edition, the venture building program has sifted through 1,500 applications, identified 110 talents, and launched 20 startups, investing in ten. With a focus on Health Tech and Biotech, Vento proves its commitment to startups at the crossroads of technology, healthcare, and biosciences, making it Italy's most active non-governmental fund. "We are the most active non-governmental fund in Italy, with a highly diversified portfolio of companies - stated Diyala D'Aveni, head of Vento at OGR Torino -. Specifically, Health Tech and Biotech together represent a significant 20% of our investments, demonstrating our dedication to startups at the intersection of technology, healthcare, and biosciences”. #VentureCapital #Startups #Innovation"

Don’t be a big Aspirin looking for a headache! Had a great time at TechBBQ, where I joined a Fireside Chat with Christian Waarst on Investors' Perspectives on Startups. We emphasized the importance of focusing on real customer problems, not just the technology. Investors are looking for solutions that solve actual pain points—innovation must be driven by need. Thanks to Anne-Marie Hall, Novo Holdings the Novo Nordisk Foundation and everyone who joined the discussion and shared insights on innovation and investment strategies! #TechBBQ #Startups #Investors #CustomerFocus #Innovation #Entrepreneurship

Workshop 4 is just around the corner! Tomorrow will be all about startup law, and our Expert in Residence for this topic is Karim Maizar! 📢 Karim is a startup and venture capital lawyer and a partner at Kellerhals Carrard. In his role, Karim works with many of Switzerland’s most promising technology and life sciences start-ups during all phases of their growth, from university spin-offs and initial seed rounds to growth financing rounds and exit transactions. Thanks for supporting our program ever since 2017, Karim! We are looking forward to hearing your insights from your extensive experience with top Swiss tech and life sciences startups! 🚀 #BioEntrepreneurship #Innovation #LifeSciences #Startups #BEIProgram #UZH #ETH #biomedentrepreneurship #biotech #medtech #digitalhealth #Entrepreneurship